Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Procedure
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Burch, R.C.; Buse, D.C.; Lipton, R.B. Migraine: Epidemiology, Burden, and Comorbidity. Neurol. Clin. 2019, 37, 631–649. [Google Scholar] [CrossRef]
- Stovner, L.J.; Nichols, E.; Steiner, T.J.; Abd-Allah, F.; Abdelalim, A.; Al-Raddadi, R.M.; Ansha, M.G.; Barac, A.; Bensenor, I.M.; Doan, L.P.; et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17, 954–976. [Google Scholar] [CrossRef] [Green Version]
- Schoenen, J.; Manise, M.; Nonis, R.; Gérard, P.; Timmermans, G. Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention. Rev. Neurol. 2020, 176, 788–803. [Google Scholar] [CrossRef] [PubMed]
- Wells, R.E.; Beuthin, J.; Granetzke, L. Complementary and Integrative Medicine for Episodic Migraine: An Update of Evidence from the Last 3 Years. Curr. Pain Headache Rep. 2019, 23, 10. [Google Scholar] [CrossRef] [PubMed]
- Puledda, F.; Shields, K. Non-Pharmacological Approaches for Migraine. Neurother. J. Am. Soc. Exp. Neurother. 2018, 15, 336–345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bahrampour, N.; Mirzababaei, A.; Yarizadeh, H.; Barekzai, A.M.; Khorsha, F.; Clark, C.C.T.; Mirzaei, K. The relationship between dietary nutrients patterns and intensity and duration of migraine headaches. Br. J. Nutr. 2022, 17, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Di Vincenzo, A.; Beghetto, M.; Vettor, R.; Tana, C.; Rossato, M.; Bond, D.S.; Pagano, C. Effects of Surgical and Non-surgical Weight Loss on Migraine Headache: A Systematic Review and Meta-Analysis. Obes. Surg. 2020, 30, 2173–2185. [Google Scholar] [CrossRef] [PubMed]
- Razeghi Jahromi, S.; Ghorbani, Z.; Martelletti, P.; Lampl, C.; Togha, M. Association of diet and headache. J. Headache Pain 2019, 20, 106. [Google Scholar] [CrossRef] [Green Version]
- Arora, N.; Mehta, T.R. Role of the ketogenic diet in acute neurological diseases. Clin. Neurol. Neurosurg. 2020, 192, 105727. [Google Scholar] [CrossRef]
- Di Lorenzo, C.; Ballerini, G.; Barbanti, P.; Bernardini, A.; D’Arrigo, G.; Egeo, G.; Frediani, F.; Garbo, R.; Pierangeli, G.; Prudenzano, M.P.; et al. Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations. Nutrients 2021, 13, 2307. [Google Scholar] [CrossRef]
- Wheless, J.W. History of the ketogenic diet. Epilepsia 2008, 49 (Suppl. S8), 3–5. [Google Scholar] [CrossRef]
- Schoeler, N.E.; Cross, J.H. Ketogenic dietary therapies in adults with epilepsy: A practical guide. Pract. Neurol. 2016, 16, 208–214. [Google Scholar] [CrossRef] [Green Version]
- Strahlman, R.S. Can ketosis help migraine sufferers? A case report. Headache 2006, 46, 182. [Google Scholar] [CrossRef]
- Di Lorenzo, C.; Currà, A.; Sirianni, G.; Coppola, G.; Bracaglia, M.; Cardillo, A.; De Nardis, L.; Pierelli, F. Diet transiently improves migraine in two twin sisters: Possible role of ketogenesis? Funct. Neurol. 2013, 28, 305–308. [Google Scholar] [CrossRef]
- Di Lorenzo, C.; Coppola, G.; Sirianni, G.; Di Lorenzo, G.; Bracaglia, M.; Di Lenola, D.; Siracusano, A.; Rossi, P.; Pierelli, F. Migraine improvement during short lasting ketogenesis: A proof-of-concept study. Eur. J. Neurol. 2015, 22, 170–177. [Google Scholar] [CrossRef]
- Di Lorenzo, C.; Pinto, A.; Ienca, R.; Coppola, G.; Sirianni, G.; Di Lorenzo, G.; Parisi, V.; Serrao, M.; Spagnoli, A.; Vestri, A.; et al. A Randomized Double-Blind, Cross-Over Trial of very Low-Calorie Diet in Overweight Migraine Patients: A Possible Role for Ketones? Nutrients 2019, 11, 1742. [Google Scholar] [CrossRef] [Green Version]
- Bongiovanni, D.; Benedetto, C.; Corvisieri, S.; Del Favero, C.; Orlandi, F.; Allais, G.; Sinigaglia, S.; Fadda, M. Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2021, 42, 3865–3870. [Google Scholar] [CrossRef]
- Peterlin, B.L.; Rapoport, A.M.; Kurth, T. Migraine and obesity: Epidemiology, mechanisms, and implications. Headache 2010, 50, 631–648. [Google Scholar] [CrossRef] [Green Version]
- Rivera-Mancilla, E.; Al-Hassany, L.; Villalón, C.M.; MaassenVanDenBrink, A. Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus. Front. Neurol. 2021, 12, 835. [Google Scholar] [CrossRef]
- Paoli, A. Ketogenic diet for obesity: Friend or foe? Int. J. Environ. Res. Public Health 2014, 11, 2092–2107. [Google Scholar] [CrossRef] [Green Version]
- Bruci, A.; Tuccinardi, D.; Tozzi, R.; Balena, A.; Santucci, S.; Frontani, R.; Mariani, S.; Basciani, S.; Spera, G.; Gnessi, L.; et al. Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients With Obesity and Mild Kidney Failure. Nutrients 2020, 12, 333. [Google Scholar] [CrossRef] [Green Version]
- Paoli, A.; Cenci, L.; Pompei, P.; Sahin, N.; Bianco, A.; Neri, M.; Caprio, M.; Moro, T. Effects of Two Months of Very Low Carbohydrate Ketogenic Diet on Body Composition, Muscle Strength, Muscle Area, and Blood Parameters in Competitive Natural Body Builders. Nutrients 2021, 13, 374. [Google Scholar] [CrossRef]
- Olesen, J.; Bendtsen, L.; Dodick, D.; Ducros, A.; Evers, S.; First, M.; Goadsby, P.J.; Hershey, A.; Katsarava, Z.; Levin, M.; et al. Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018, 38, 1–211. [Google Scholar] [CrossRef]
- Scott, W.; McCracken, L.M. Patients’ impression of change following treatment for chronic pain: Global, specific, a single dimension, or many? J. Pain 2015, 16, 518–526. [Google Scholar] [CrossRef]
- Gregor, M.F.; Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415–445. [Google Scholar] [CrossRef] [Green Version]
- Barbanti, P.; Fofi, L.; Aurilia, C.; Egeo, G.; Caprio, M. Ketogenic diet in migraine: Rationale, findings and perspectives. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2017, 38, 111–115. [Google Scholar] [CrossRef]
- Erdener, Ş.E.; Kaya, Z.; Dalkara, T. Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J. Headache Pain 2021, 22, 138. [Google Scholar] [CrossRef] [PubMed]
- Valente, M.; Del Negro, I.; Bagatto, D.; Garbo, R.; Lettieri, C.; Bernardini, A.; Nilo, A.; Peri, M.R.; Pecori, D.; Gigli, G.L. Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet. BMJ Neurol. Open 2021, 3, e000176. [Google Scholar] [CrossRef] [PubMed]
- Storoni, M.; Plant, G.T. The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Mult. Scler. Int. 2015, 2015, 681289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bough, K.J.; Wetherington, J.; Hassel, B.; Pare, J.F.; Gawryluk, J.W.; Greene, J.G.; Shaw, R.; Smith, Y.; Geiger, J.D.; Dingledine, R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60, 223–235. [Google Scholar] [CrossRef]
- Di Lorenzo, C.; Coppola, G.; Bracaglia, M.; Di Lenola, D.; Evangelista, M.; Sirianni, G.; Rossi, P.; Di Lorenzo, G.; Serrao, M.; Parisi, V.; et al. Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: A multimodal evoked potentials study. J. Headache Pain 2016, 17, 58. [Google Scholar] [CrossRef] [Green Version]
- Di Lorenzo, C.; Coppola, G.; Bracaglia, M.; Di Lenola, D.; Sirianni, G.; Rossi, P.; Di Lorenzo, G.; Parisi, V.; Serrao, M.; Cervenka, M.C.; et al. A ketogenic diet normalizes interictal cortical but not subcortical responsivity in migraineurs. BMC Neurol. 2019, 19, 136. [Google Scholar] [CrossRef]
- Valente, M.; Lettieri, C.; Russo, V.; Janes, F.; Gigli, G.L. Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine. Toxins 2021, 13, 392. [Google Scholar] [CrossRef]
- de Tommaso, M.; Delussi, M. Nociceptive blink reflex habituation biofeedback in migraine. Funct. Neurol. 2017, 32, 123–130. [Google Scholar] [CrossRef]
- Wolkodoff, N.E.; Haase, G.M.; Firger, R.A. The effects of a unique medium chain triglyceride complex on migraine symptoms: A beta pilot study. World J. Adv. Res. Rev. 2020, 8, 175–183. [Google Scholar] [CrossRef]
- Haslam, R.L.; Bezzina, A.; Herbert, J.; Spratt, N.; Rollo, M.E.; Collins, C.E. Can Ketogenic Diet Therapy Improve Migraine Frequency, Severity and Duration? Healthcare 2021, 9, 1105. [Google Scholar] [CrossRef]
- Evcili, G.; Utku, U.; Öğün, M.N.; Özdemir, G. Early and long period follow-up results of low glycemic index diet for migraine prophylaxis. Agri Agri Dern. Yayin Organidir J. Turk. Soc. Algol. 2018, 30, 8–11. [Google Scholar] [CrossRef]
- Finsterer, J.; Frank, M. Low-Glycemic-Index Diet Relieving Migraine but Inducing Muscle Cramps. J. Neurosci. Rural Pract. 2019, 10, 552–554. [Google Scholar] [CrossRef] [Green Version]
- Di Lorenzo, C.; Coppola, G.; Di Lenola, D.; Evangelista, M.; Sirianni, G.; Rossi, P.; Di Lorenzo, G.; Serrao, M.; Pierelli, F. Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial. Front. Neurol. 2018, 9, 64. [Google Scholar] [CrossRef] [Green Version]
Patient Characteristics | Absolute Frequency | Relative Frequency |
---|---|---|
Female sex | 22 | 95.6% |
Migraine without aura | 15 | 65.2% |
Migraine with aura | 8 | 34.8% |
Episodic migraine | 13 | 47.8% |
Chronic migraine | 10 | 43.4% |
Superimposed medication overuse headache | 6 | 26.1% |
Migraine Prophylactic Therapy | Absolute Frequency |
---|---|
Beta blockers | 3 |
Anti-epileptic drugs | 6 |
Antidepressants | 7 |
Onabotulinum toxin A | 4 |
Monoclonal antibodies | 4 |
Nutritional Characteristics | Baseline (Mean ± SD) | 3 Months (Mean ± SD) | p-Value |
---|---|---|---|
Weight (kg) | 73.8 ± 15.2 | 68.4 ± 14.6 | <0.001 |
Body mass index (BMI) (kg/m2) | 26.9 ± 6.2 | 23.7 ± 8.1 | <0.001 |
Phase angle | 5.0 ± 0.7 | 5.3 ± 0.5 | 0.422 |
Lean mass (kg) | 47.1 ± 8.1 | 47.9 ± 7.3 | 0.802 |
Fat mass (kg) | 28.6 ± 12.5 | 20.6 ± 9.8 | <0.001 |
Total body water (L) | 34.8 ± 4.9 | 35.1 ± 5.9 | 0.627 |
Intracellular water (L) | 17.0 ± 3.2 | 13.6 ± 3.3 | 0.333 |
Extracellular water (L) | 17.6 ± 2.5 | 17.2 ± 2.9 | 0.930 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Valente, M.; Garbo, R.; Filippi, F.; Antonutti, A.; Ceccarini, V.; Tereshko, Y.; Di Lorenzo, C.; Gigli, G.L. Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes. J. Clin. Med. 2022, 11, 4946. https://doi.org/10.3390/jcm11174946
Valente M, Garbo R, Filippi F, Antonutti A, Ceccarini V, Tereshko Y, Di Lorenzo C, Gigli GL. Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes. Journal of Clinical Medicine. 2022; 11(17):4946. https://doi.org/10.3390/jcm11174946
Chicago/Turabian StyleValente, Mariarosaria, Riccardo Garbo, Francesca Filippi, Alice Antonutti, Veronica Ceccarini, Yan Tereshko, Cherubino Di Lorenzo, and Gian Luigi Gigli. 2022. "Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes" Journal of Clinical Medicine 11, no. 17: 4946. https://doi.org/10.3390/jcm11174946